3,981 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2267457/castle-biosciences-inc-cstl-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267457 May 02, 2024 - Castle Biosciences (CSTL) delivered earnings and revenue surprises of 75.68% and 6.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Acco Brands (ACCO) Tops Q1 Earnings Estimates https://www.zacks.com/stock/news/2267458/acco-brands-acco-tops-q1-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267458 May 02, 2024 - Acco (ACCO) delivered earnings and revenue surprises of 50% and 3.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2267434/ardelyx-ardx-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267434 May 02, 2024 - Ardelyx (ARDX) delivered earnings and revenue surprises of 15.38% and 25.64%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ModivCare (MODV) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2267439/modivcare-modv-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267439 May 02, 2024 - ModivCare (MODV) delivered earnings and revenue surprises of -145% and 2.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
2U (TWOU) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2267436/2u-twou-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267436 May 02, 2024 - 2U (TWOU) delivered earnings and revenue surprises of 35.29% and 1.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SM Energy (SM) Tops Q1 Earnings Estimates https://www.zacks.com/stock/news/2267438/sm-energy-sm-tops-q1-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267438 May 02, 2024 - SM Energy (SM) delivered earnings and revenue surprises of 10.16% and 1.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Olympic Steel (ZEUS) Tops Q1 Earnings Estimates https://www.zacks.com/stock/news/2267437/olympic-steel-zeus-tops-q1-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267437 May 02, 2024 - Olympic Steel (ZEUS) delivered earnings and revenue surprises of 5.48% and 4.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2267440/cardiff-oncology-crdf-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267440 May 02, 2024 - Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 12% and 86.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2267446/relay-therapeutics-inc-rlay-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267446 May 02, 2024 - Relay Therapeutics (RLAY) delivered earnings and revenue surprises of 11.43% and 2,905.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Magnachip (MX) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2267447/magnachip-mx-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267447 May 02, 2024 - Magnachip (MX) delivered earnings and revenue surprises of 15.15% and 0.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
<<<Page 217>